Detailed safety profile of acalabrutinib vs ibrutinib in CLL, inflammation in trauma-induced coagulopathy, abatacept exposure and acute GVHD risk
This episode discusses the safety profiles of acalabrutinib and ibrutinib in chronic lymphocytic leukemia, examines how leukocyte inflammation contributes to trauma-induced coagulopathy, and analyzes the relationship between abatacept exposure and the risk of acute graft versus…